Microtubules in Apoptosis Induction: Are They Necessary?
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
713-729
Author(s):
D. Braguer, M. Carre and M.-A. Esteve
How Do Microtubule-Targeted Drugs Work? An Overview
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
730-742
Author(s):
Mary Ann Jordan and Kathy Kamath
Molecular and Cellular Regulators of Cancer Angiogenesis
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
743-758
Author(s):
P. P. Goh, D. M. Sze and B. D. Roufogalis
Radiosensitization of Prostate Cancer by Soy Isoflavones
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
759-765
Author(s):
Julian J. Raffoul, Fazlul H. Sarkar and Gilda G. Hillman
Novel Mitotic Targets and Their Small-Molecule Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
766-784
Author(s):
Alexandre V. Ivachtchenko, Alex S. Kiselyov, Sergey E. Tkachenko, Yan A. Ivanenkov and Konstantin V. Balakin
IAPs as a Target for Anticancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
785-794
Author(s):
S. Danson, E. Dean, C. Dive and M. Ranson
Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
795-809
Author(s):
A. Ortuno, O. Benavente-Garcia, J. Castillo, M. Alcaraz, V. Vicente and J. A. Del Rio
Use of Mouse Models to Evaluate Roles of Nuclear Receptors and their Ligands in the Pathogenesis and Treatment of Atherosclerosis
Journal:
Current Drug Targets
Volume:
8
Page:
1273-1287
Author(s):
A. C. Li and C. K. Glass
RAGE and RAGE Ligands in Cancer
Journal:
Current Molecular Medicine
Volume:
7
Page:
777-789
Author(s):
Craig D. Logsdon, Maren K. Fuentes, Emina H. Huang and Thiruvengadam Arumugam
Controlled-release Particulate Cytokine Adjuvants for Cancer Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
266-270
Author(s):
Nejat K. Egilmez, Mehmet O. Kilinc, Tao Gu and Thomas F. Conway